Key Takeaways:
- Insulcheck is a medical startup company based in Dublin, Ireland that aids in eliminating the risk for insulin pen users of double injecting or missing a dose
- The company was formed in 2009 by founders John Hughes and William Cirillo, out of Hughes’s personal encounter with an accidental double injection
- Using a simple clip-on add-on to the insulin pen, InsulCheck records the time since the last injection was administered
A common struggle for insulin-dependent individuals is remembering the timing of their last insulin injection. It’s an issue that has potentially dangerous, even life-threatening outcomes if a dose is missed or doubled. One startup out of Dublin, Ireland, Insulcheck, has aimed to address this very issue. The company, founded in 2009 by John Hughes and William Cirillo, is centred around a simple yet innovative solution that monitors the time since the last injection for insulin pen users.
John Hughes, who himself has Type 1 diabetes, set up the company after suffering a hypoglycaemic event from mistakenly double injecting. During his recovery, Hughes thought about how he could prevent himself and others from making the same error again, hence InsulCheck was born. The device offers security to both insulin-dependent individuals and their care team by tracking the time since the last injection was given.
So how does Insulcheck carve out a space for itself in the healthcare sector? The differential lies in its simplicity and practicality. Insulcheck is a light, compact add-on that fits onto an existing insulin pen. It doesn’t require complex systems or expensive equipment; it simply answers the question ‘when did I last inject?’ with clarity. In doing so, it helps decrease the chances of a missed or double dose. The device allows insulin-dependent individuals and their families to worry less about injection timings, providing peace of mind like never before.
Furthermore, it eliminates the need for patients to remember or manually record their insulin injections, thus reducing errors and saving precious time. It also has the potential to improve adherence to medication regimens, something that has been shown to significantly improve health outcomes in chronic diseases such as diabetes.
As Insulcheck continues to grow, they are committed to enhancing the lives of insulin-dependent individuals by offering a clear and easy to use solution to the anxiety-provoking problem of injection timing. The impact of Insulcheck may well stretch beyond diabetes care, with potential applications in other medication regimens that require strict scheduling.
While the healthcare sector continues to evolve, particularly around the management of chronic diseases like diabetes, companies such as Insulcheck will have a significant role to play in driving this evolution. By bridging the gap between technology and patient care, Insulcheck and similar companies are making strides in improving the lives of people living with chronic conditions every day.
To find out more about Insulcheck, visit their website, or follow them on Twitter, Facebook and LinkedIn.
Want to amplify your startup’s story? EU Startup News is your launchpad to reach startup founders, investors, and C-level execs across Europe. Discover our tailored promotional strategies such as Sponsored Articles and Partnerships. Click here to learn more or contact us directly at [email protected]. Join us, and let’s make your startup the talk of Europe!
